Skip to main content

Table 2 Clinical characteristics of the two groups

From: The increased prevalence of depression and anxiety in T2DM patients associated with blood glucose fluctuation and sleep quality

 

Comorbidity group

(n = 81)

Control group

(n = 101)

F/χ2

P

Hba1c

9.62 ± 2.45

9.90 ± 2.58

0.55

0.457

Triglycerides

1.70 ± 0.85

2.07 ± 1.59

3.46

0.065

Total cholesterol

4.44 ± 1.13

4.40 ± 1.23

0.06

0.811

ALT

27.04 ± 28.75

35.83 ± 36.18

3.18

0.076

AST

22.00 ± 17.52

25.13 ± 23.32

-0.59

0.122

Creatinine, μmol/L

65.55 ± 25.37

69.81 ± 25.18

1.26

0.264

25-dihydroxyvitamin-D

14.98 ± 7.06

16.37 ± 6.80

1.78

0.184

Serum calcium

2.37 ± 0.16

2.39 ± 0.13

0.70

0.404

Serum phosphate

1.16 ± 0.21

1.18 ± 0.18

0.38

0.539

UA

318.5 ± 112.65

347.76 ± 126.66

2.63

0.107

FT3

4.20 ± 2.37

4.06 ± 1.56

0.24

0.626

FT4

13.91 ± 3.57

14.26 ± 3.59

0.41

0.524

TSH

1.97 ± 1.46

1.89 ± 1.21

0.15

0.699

TPO-Ab

40.63 ± 152.11

21.57 ± 69.73

1.19

0.277

TG-Ab

20.24 ± 82.29

25.08 ± 79.97

0.15

0.695

Cortisol (8:00 AM)

344.42 ± 98.11

335.37 ± 127.53

0.23

0.636

Cortisol (16:00 PM)

195.59 ± 86.33

183.56 ± 82.97

0.72

0.399

Cortisol (24:00 PM)

126.53 ± 93.73

124.73 ± 97.32

0.01

0.912

C-peptide level

1.47 ± 0.96

1.61 ± 0.91

0.89

0.346

C-peptide level(1 h)

2.73 ± 2.43

3.60 ± 7.13

0.82

0.366

C-peptide level(2 h)

4.11 ± 3.19

5.17 ± 6.62

1.62

0.205

FBG

8.72 ± 2.67

8.41 ± 2.73

0.55

0.460

PBG(1 h)

13.88 ± 4.58

13.39 ± 3.47

0.52

0.474

PBG(2 h)

16.45 ± 5.33

15.93 ± 4.92

0.45

0.506

SDBGa

1.29 ± 1.29

0.98 ± 0.34

4.68

0.032

PPGEa

2.61 ± 3.11

1.83 ± 1.36

4.43

0.037

LAGE

7.45 ± 8.34

6.23 ± 2.40

1.72

0.192

  1. aThe difference was statistically significant